Corvus Pharmaceuticals (CRVS) EPS (2016 - 2026)
Corvus Pharmaceuticals (CRVS) EPS from Mar 31, 2016 to Mar 31, 2026. The TTM Corvus Pharmaceuticals (CRVS) EPS is -$0.57. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Corvus Pharmaceuticals (CRVS) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.28% |
| 3 Years TTM | -13.36% |
| 5 Years TTM | +53.96% |
| 10 Years TTM | +6.26% |
| All Time TTM | -13.93% |
Annual EPS change of Corvus Pharmaceuticals (CRVS)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.16 | -20.41% |
| 2025 | -$0.20 | -77.70% |
| 2024 | -$0.92 | +66.43% |
| 2023 | -$0.55 | -37.88% |
| 2022 | -$0.89 | -4.46% |
| 2021 | -$0.93 | +339.95% |
| 2020 | -$0.21 | -87.35% |
| 2019 | -$1.67 | +4.30% |
| 2018 | -$1.60 | -39.49% |
| 2017 | -$2.65 | +52.17% |
| 2016 | -$1.74 | N/A |
Comparison Corvus Pharmaceuticals (CRVS) five years EPS CAGR with competitors
Corvus Pharmaceuticals (CRVS) five years EPS CAGR is 53.96%.